Mesothelioma researchers from the University of Hawaii Cancer Center have seen promising results from the application of a treatment protocol for multiple sclerosis (MS). The researchers are investigating the use of an immune system modulator called FTY720which comes from a fungus called Iscaria Sinclairi. The results were published in The Journey of Translational Medicine.
Scientists believe that FTY720 has potential therapeutic applications for other cancers as well but the University of Hawaii’s tests represent the first time that the treatment has been used for pleural mesothelioma. Currently the test has just been performed on mice but the results are promising.
Agata Szymiczek, author of the published study, stated that, “FTY720 administration in vivo [in a live subject] effectively reduced tumor burden in mice without apparent toxicity.” While there is still much work to be done, we remain hopeful that there may be positive results in the near future.
The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.
Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers.
